It was reported that miR-152 can target DNMT1 and induce aberrant DNA methylation in HBV-related hepatocellular carcinoma [15] and that miR-152 targets DNMT1 in Nis-transformed cells via a feedback mechanism [37], [39]. Here, DNMT1 is linked to hepatocellular carcinoma.